Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


06.02.2017

1 Am J Hematol
13 Ann Hematol
1 Ann Oncol
2 Blood
3 Eur J Haematol
1 Gene
2 Int J Hematol
5 J Clin Oncol
6 Leuk Lymphoma
1 Leuk Res
2 Leukemia
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. JENTZSCH M, Bill M, Nicolet D, Leiblein S, et al
    Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation.
    Am J Hematol. 2017 Jan 30. doi: 10.1002/ajh.24663.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. HIRABAYASHI S, Kondo T, Oka T, Akamatsu Y, et al
    Successful treatment of severe acute gastrointestinal graft-versus-host disease complicated by cytomegalovirus gastroenteritis with intra-arterial steroid infusion.
    Ann Hematol. 2016;95:1373-5.
    PubMed     Text format    

  3. BURBACH M, Birsen R, Denis B, Munier AL, et al
    A case of BK virus nephropathy without hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Ann Hematol. 2016;95:1567-8.
    PubMed     Text format    

  4. FISCHER J, Hamacher L, Fries J, Hallek M, et al
    Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL.
    Ann Hematol. 2016;95:1569-70.
    PubMed     Text format    

  5. PEI YQ, Wu Y, Wang F, Cui W, et al
    Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
    Ann Hematol. 2016;95:1391-8.
    PubMed     Text format     Abstract available

  6. ZDRENGHEA M, Bagacean C, Renaudineau Y, Salaun PY, et al
    Isolated Cardiac Richter Syndrome: a Case Report.
    Ann Hematol. 2017;96:147-149.
    PubMed     Text format    

  7. FILIP AA, Grenda A, Popek S, Koczkodaj D, et al
    Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.
    Ann Hematol. 2017;96:33-50.
    PubMed     Text format     Abstract available

  8. PIREDDA ML, Catalano G, Ciardi C, Divona M, et al
    Identification of a potential topoisomerase II "hotspot" DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms.
    Ann Hematol. 2017;96:155-157.
    PubMed     Text format    

  9. MANGIACAVALLI S, Pompa A, Ferretti V, Klersy C, et al
    The possible role of burden of therapy on the risk of myeloma extramedullary spread.
    Ann Hematol. 2017;96:73-80.
    PubMed     Text format     Abstract available

  10. ORIOLI L, Sarti K, Van Den Neste E, Maiter D, et al
    Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia.
    Ann Hematol. 2017 Feb 1. doi: 10.1007/s00277-017-2928.
    PubMed     Text format    

  11. ITO S, Fujiwara SI, Mashima K, Umino K, et al
    Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia.
    Ann Hematol. 2017 Feb 1. doi: 10.1007/s00277-017-2933.
    PubMed     Text format     Abstract available

  12. TALAMO L, Douvas M, Macik BG, Ornan D, et al
    Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management.
    Ann Hematol. 2017 Jan 28. doi: 10.1007/s00277-017-2930.
    PubMed     Text format    


  13. ACUTE LEUKEMIAS XVI.
    Ann Hematol. 2017;96.
    PubMed     Text format    

  14. LEE JS, Cheong HS, Koh Y, Ahn KS, et al
    MCM7 polymorphisms associated with the AML relapse and overall survival.
    Ann Hematol. 2017;96:93-98.
    PubMed     Text format     Abstract available


    Ann Oncol

  15. MATO AR, Hill BT, Lamanna N, Barr PM, et al
    Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients.
    Ann Oncol. 2017 Jan 27. pii: mdx031. doi: 10.1093.
    PubMed     Text format     Abstract available


    Blood

  16. ISHIZAWA J, Sugihara E, Kuninaka S, Mogushi K, et al
    FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B cell acute leukemia.
    Blood. 2017 Jan 31. pii: blood-2016-07-726216. doi: 10.1182/blood-2016-07-726216
    PubMed     Text format     Abstract available

  17. LAOUEDJ M, Tardif MR, Gil L, Raquil MA, et al
    S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Blood. 2017 Jan 30. pii: blood-2016-09-738005. doi: 10.1182/blood-2016-09-738005
    PubMed     Text format     Abstract available


    Eur J Haematol

  18. THOTA S, Advani A
    Inotuzumab ozogamicin in relapsed b-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12862.
    PubMed     Text format     Abstract available

  19. SEKINE M, Kubuki Y, Kameda T, Takeuchi M, et al
    Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12863.
    PubMed     Text format     Abstract available

  20. LAZAREVIC V, Rosso A, Juliusson G, Antunovic P, et al
    Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: a population-based study from the Swedish AML Registry.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12861.
    PubMed     Text format     Abstract available


    Gene

  21. MEENA B, Anburajan L, Vinithkumar NV, Shridhar D, et al
    Molecular expression of l-asparaginase gene from Nocardiopsis alba NIOT-VKMA08 in Escherichia coli: A prospective recombinant enzyme for leukaemia chemotherapy.
    Gene. 2016;590:220-6.
    PubMed     Text format     Abstract available


    Int J Hematol

  22. REYNA-FIGUEROA J, Lagunas-Martinez A, Galindo-Delgado P, Fernandez-Bautista MF, et al
    Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.
    Int J Hematol. 2017 Jan 31. doi: 10.1007/s12185-016-2175.
    PubMed     Text format     Abstract available

  23. OKSENHENDLER E, Turpin J, Lhote R, Cassar O, et al
    Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.
    Int J Hematol. 2017 Jan 30. doi: 10.1007/s12185-016-2174.
    PubMed     Text format     Abstract available


    J Clin Oncol

  24. LICHTMAN MA
    Clonal Cytopenias and Oligoblastic Myelogenous Leukemia (myelodysplasia) Have Neoplastic, not Hyperplastic, Erythropoiesis.
    J Clin Oncol. 2017 Jan 30:JCO2016704056. doi: 10.1200/JCO.2016.70.4056.
    PubMed     Text format    

  25. ALLAN JN, Howes AJ, Mahler M, Wildgust MA, et al
    Comparing overall survival (OS) outcomes in patients with newly diagnosed chronic lymphocytic leukemia (CLL) with normal life expectancy.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  26. SMITH BD, Hourigan CS, Gojo I, Pratz KW, et al
    A single-center survey of health-related quality of life among acute myeloid leukemia survivors in first complete remission.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  27. BRINKMAN TM, Cheung YT, Pui CH, Hudson MM, et al
    Functional consequence of cognitive impairment in survivors of childhood acute lymphoblastic leukemia (ALL): The role of cancer symptoms as mediators.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  28. KOH JW, Chin F, Teh YH, Chan MY, et al
    Second neoplasms in survivors of childhood acute lymphoblastic leukemia treated with both chemotherapy and radiotherapy.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  29. ZHOU G, Cao Y, Dong W, Lin Y, et al
    The clinical characteristics and prognostic significance of AID, miR-181b, and miR-155 expression in adult patients with de novo B-cell acute lymphoblastic leukemia.
    Leuk Lymphoma. 2017 Jan 31:1-12. doi: 10.1080/10428194.2017.1283028.
    PubMed     Text format     Abstract available

  30. CHANG YC, Lo WJ, Huang YT, Lin CL, et al
    Deferasirox has strong anti-leukemia activity but may antagonize theanti-leukemia effect of doxorubicin.
    Leuk Lymphoma. 2017 Jan 31:1-12. doi: 10.1080/10428194.2017.1280604.
    PubMed     Text format     Abstract available

  31. NAN X, Qin Q, Gentille C, Ensor J, et al
    Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Leuk Lymphoma. 2017 Jan 31:1-11. doi: 10.1080/10428194.2016.1277386.
    PubMed     Text format     Abstract available

  32. LOEFF FC, van Egmond HM, Nijmeijer BA, Falkenburg JH, et al
    Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors.
    Leuk Lymphoma. 2017 Jan 31:1-14. doi: 10.1080/10428194.2017.1281411.
    PubMed     Text format     Abstract available

  33. KRULL K, Kunstreich M, Klasen-Sansone J, Kloetgen A, et al
    Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trial.
    Leuk Lymphoma. 2017 Jan 31:1-10. doi: 10.1080/10428194.2017.1280605.
    PubMed     Text format     Abstract available

  34. NAGEL S, Pommerenke C, Meyer C, Kaufmann M, et al
    Identification of a tumor suppressor network in T-cell leukemia.
    Leuk Lymphoma. 2017 Jan 31:1-15. doi: 10.1080/10428194.2017.1283029.
    PubMed     Text format     Abstract available


    Leuk Res

  35. PATEL JL, Schumacher JA, Frizzell K, Sorrells S, et al
    Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Leuk Res. 2017;56:7-12.
    PubMed     Text format     Abstract available


    Leukemia

  36. CHANAN-KHAN A, Egyed M, Robak T, de Oliveira FA, et al
    Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).
    Leukemia. 2017 Jan 31. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  37. WATTAD M, Weber D, Dohner K, Krauter J, et al
    Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure.
    Leukemia. 2017 Jan 19. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    PLoS One

  38. NAGEL S, Pommerenke C, Scherr M, Meyer C, et al
    NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
    PLoS One. 2017;12:e0171164.
    PubMed     Text format     Abstract available

  39. EL MISSIRY M, Hjorth-Hansen H, Richter J, Olson-Stromberg U, et al
    Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
    PLoS One. 2017;12:e0171041.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: